Recap: Biora Therapeutics Q3 Earnings
Portfolio Pulse from Benzinga Insights
Biora Therapeutics (NASDAQ:BIOR) reported Q3 earnings with an EPS of $-0.75, slightly beating estimates by 1.32% but with a revenue decrease of $80 thousand from the previous year. The company's past earnings beat resulted in a 0.95% share price drop the following day.
November 13, 2023 | 9:40 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Biora Therapeutics reported a marginal earnings beat but experienced a decrease in revenue compared to last year. Historical response to earnings beat was a slight drop in share price.
While BIOR beat EPS estimates, the decrease in revenue and historical price drop following the last earnings beat suggest a potential negative short-term impact on the stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100